You are here: Industry Insights > share

News List

Clariant Chemicals’ declares Special Interim Dividend of Rs. 140/- per share expresspharma
July 13, 2020
This Special Interim Dividend shall be paid on or after July 19, 2020.
Medical marketing spend is inching toward $30B, and DTC's share is growing fiercepharma
January 13, 2019
It’s no surprise that medical marketing spending has skyrocketed in the past 20 years. And while marketing to physicians continues to consume the lion's share of the almost $30 billion spent overall, direct-to-consumer marketing is catching up.
InvaGen to acquire Avenue Therapeutics for $215m pharmaceutical-technology
November 14, 2018
InvaGen Pharmaceuticals, a unit of India-based Cipla, has signed definitive agreements to buy US-based specialty pharmaceutical firm Avenue Therapeutics for a total consideration of $215m.
InvaGen to acquire Avenue Therapeutics for $215m pharmaceutical-technology
November 14, 2018
InvaGen Pharmaceuticals, a unit of India-based Cipla, has signed definitive agreements to buy US-based specialty pharmaceutical firm Avenue Therapeutics for a total consideration of $215m.
AstraZeneca receives European clearance for lung cancer drug SHARE pharmaceutical-technology
June 13, 2018
AstraZeneca has secured marketing clearance from the European Commission (EC) for its Tagrisso (osimertinib) drug to treat non-small cell lung cancer (NSCLC) in adults.
Jenburkt Pharma to consider share buyback expressbpd
September 08, 2017
Jenburkt Pharmaceuticals’ board will meet later this week to consider buy back of equity shares, sending its stock up by 8 per cent.